Mantero F, Opocher G, Boscaro M, Valpione E, Armanini D, Fallo F
Horm Metab Res. 1981 Aug;13(8):464-7. doi: 10.1055/s-2007-1019302.
The behaviour of plasma renin, aldosterone, cortisol and prolactin after administration of a drug with antidopaminergic action, metoclopramide, was evaluated in 6 normal subjects, 8 patients affected by primary aldosteronism and in 5 patients affected by anterior hypopituitarism. In the first two groups, besides the predictable increase of prolactin under metoclopramide, a significant aldosterone increase was noted. Cortisol remained unchanged, and PRA was not significantly increased. A similar pattern of aldosterone, cortisol and PRA was also found in patients with hypopituitarism. However, the plasma prolactin did not increase in this group. The comparative examination of three groups of patients leads us to conclude that aldosterone increase is not imputable to ACTH, renin or to prolactin. This may be explained by a possible direct effect of the antidopaminergic drug at the adrenal level, which is more likely than an effect through some yet undetermined factor.
在6名正常受试者、8名原发性醛固酮增多症患者和5名垂体前叶功能减退症患者中,评估了给予具有抗多巴胺能作用的药物甲氧氯普胺后血浆肾素、醛固酮、皮质醇和催乳素的行为。在前两组中,除了甲氧氯普胺作用下催乳素可预见的升高外,还观察到醛固酮显著升高。皮质醇保持不变,血浆肾素活性未显著增加。在垂体功能减退症患者中也发现了类似的醛固酮、皮质醇和血浆肾素活性模式。然而,该组患者的血浆催乳素并未升高。对三组患者的比较检查使我们得出结论,醛固酮升高并非归因于促肾上腺皮质激素、肾素或催乳素。这可能是由于抗多巴胺能药物在肾上腺水平可能存在直接作用,这比通过某些尚未确定的因素产生的作用更有可能。